{"id":"NCT05630833","sponsor":"GlaxoSmithKline","briefTitle":"A Study to Investigate the Efficacy and Safety With Gepotidacin in Japanese Female Participants With Uncomplicated Urinary Tract Infection (Acute Cystitis)","officialTitle":"A Phase III, Multicenter, Randomized, Active Reference, Double Blind, Double-dummy Study in Japanese Female Participants to Evaluate the Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2023-01-11","primaryCompletion":"2024-02-02","completion":"2024-02-02","firstPosted":"2022-11-30","resultsPosted":"2025-03-17","lastUpdate":"2025-03-17"},"enrollment":380,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Urinary Tract Infections"],"interventions":[{"type":"DRUG","name":"Gepotidacin","otherNames":[]},{"type":"DRUG","name":"Nitrofurantoin","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Gepotidacin + Placebo","type":"EXPERIMENTAL"},{"label":"Nitrofurantoin + Placebo","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the consistency of therapeutic response of gepotidacin in female participants with acute uncomplicated cystitis with qualifying bacterial uropathogen(s) at baseline that all are susceptible to nitrofurantoin in Japan, with that from global studies (Studies 204989 \\[NCT04020341\\] and 212390 \\[NCT04187144\\]).","primaryOutcome":{"measure":"Number of Participants With Therapeutic Response (TR) (Combined Per-participant Microbiological and Clinical Success) for Gepotidacin at the Test of Cure (TOC) Visit","timeFrame":"At TOC visit (Days 9 to 16)","effectByArm":[{"arm":"Gepotidacin","deltaMin":69,"sd":null}],"pValues":[{"comp":"OG000","p":null}]},"eligibility":{"minAge":"12 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":27},"locations":{"siteCount":27,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":281},"commonTop":["Diarrhoea","Nausea"]}}